Stryker Corp
Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually.
Trading 38% above its estimated fair value of $206.96.
Current Price
$331.54
+0.65%GoodMoat Value
$206.96
37.6% overvaluedStryker Corp (SYK) Reverse DCF
Stryker Corp — Reverse DCF
SYK · NYSE · Healthcare
GoodMoat Target
“When a medical device maker trades at nearly 39 times earnings, you're paying champagne prices for what better be Dom Pérignon quality growth.”
— In the voice of Buffett
What is the Reverse DCF?
Determine what growth rate the market is pricing in. Compare implied growth against historical performance to identify mispricing.
Key Metrics
Market Cap
$126.79B
P/E Ratio
39.06
Forward P/E
—
EPS
$8.40
PEG Ratio
0.72
Book Value
$58.63
Dividend Yield
1.01%
Profit Margin
12.92%
ROE
14.48%
Reverse DCF Analysis
Implied Growth
15.1%
Market expects high growth — price may already embed a growth premium.
VS BENCHMARKS
At 10% conservative growth:
Fair Value
$247.07
MOS
-34%
Buy Below
$185.30
Adjust Parameters
Stryker Corp (SYK) Reverse DCF
Determine what growth rate the market is pricing in. Compare implied growth against historical performance to identify mispricing.
Stryker Corp is a Healthcare company in the Medical Devices industry, listed on NYSE. Current stock price: $331.54. Market capitalization: $126.79B. EPS: $8.40. P/E ratio: 39.06.
GoodMoat Fair Value target: $206.96. The stock appears 60.2% overvalued based on our blended model.
Use GoodMoat's Reverse DCF alongside other valuation tools including DCF Calculator, Reverse DCF, Fair Value models, and Quality Score to build a comprehensive investment thesis for Stryker Corp (SYK). All tools are free to use and powered by real-time financial data.